COMPLETED

Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health

Talk to us

Conditions

Gastrointestinal DiseaseGastrointestinal DisordersNervous SystemIrritable Bowel SyndromeGastroesophageal Reflux Disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.

Official Title

The Use of Telehealth-Delivered Gut-Directed Hypnotherapy for Managing Gastrointestinal Health

Quick Facts

Study Start:2025-03-19
Study Completion:2025-10-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06890663

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years or older
  2. * Self reported gastrointestinal symptoms consistent with disorders of gut-brain interaction
  3. * English speaking
  4. * Willingness to participate in all hypnotherapy sessions \& complete all pre- and post-session surveys
  1. * Under 18 years
  2. * Pregnant women
  3. * Prisoners
  4. * Children
  5. * Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders)
  6. * A hypnotic susceptibility score in the low range (SHSS; total = 0-3)

Contacts and Locations

Principal Investigator

Jeffrey Cassisi, PhD
PRINCIPAL_INVESTIGATOR
University of Central Florida

Study Locations (Sites)

University of Central Florida
Orlando, Florida, 32816
United States

Collaborators and Investigators

Sponsor: University of Central Florida

  • Jeffrey Cassisi, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-19
Study Completion Date2025-10-30

Study Record Updates

Study Start Date2025-03-19
Study Completion Date2025-10-30

Terms related to this study

Keywords Provided by Researchers

  • Irritable Bowel Syndrome
  • Gastroesophageal Reflux Disease

Additional Relevant MeSH Terms

  • Gastrointestinal Disease
  • Gastrointestinal Disorders
  • Nervous System